Skip to content

A Trial to Investigate the Accuracy of a Wearable Device in Collecting Data Related to Perimenopausal Symptoms in Women

An Observational Virtual Trial to Investigate the Accuracy of a Wearable Device in Collecting Data Related to Perimenopausal Symptoms in Women

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07022925
Enrollment
110
Registered
2025-06-15
Start date
2025-07-04
Completion date
2025-10-31
Last updated
2025-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopausal and Postmenopausal Disorders, Menopausal Depression, Menopausal Hot Flashes, Menopausal Vasomotor Symptoms, Perimenopausal Depression, Perimenopausal Insomnia, Perimenopausal Women, Perimenopause

Keywords

Menopause, Perimenopause, Vasomotor symptoms, Hot flashes, IdentifyHer, Peri, Perimenopausal symptoms

Brief summary

The goal of this observational study is to investigate the accuracy of the device in characterizing perimenopausal and menopausal symptoms including vasomotor symptoms, anxiety, sleep quality compared to self-reported symptoms via an app. The main question it aims to answer is: What is the accuracy of the developed algorithm from the investigational device compared to daily self-report via an app in characterizing perimenopausal symptoms? Participants will be asked to wear IndentifyHer's wearable non-invasive sensor and complete a daily electronic diary and questionnaires on stress, anxiety, and sleep.

Interventions

None listed

Sponsors

KGK Science Inc.
CollaboratorINDUSTRY
IdentifyHer Limited
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
35 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

1. Females between 35-55 years of age, inclusive 2. Self-reported perimenopausal women experiencing hot flushes or night sweats 3. Individuals of child-bearing potential must confirm they are not pregnant, do not plan to become pregnant, and agree to use a medically approved method of birth control for the duration of the study. Acceptable methods of birth control include: * Double-barrier method * Intrauterine devices * Non-heterosexual lifestyle or agrees to use contraception if planning on changing to heterosexual partner(s) * Vasectomy of partner at least 6 months prior to screening * Abstinence 4. Agrees to maintain current lifestyle as much as possible throughout the study, including diet, exercise, supplements/medications, and sleep 5. Provided voluntary and informed consent to participate in the study 6. Generally healthy as determined by medical history with no unstable diagnosed medical conditions

Exclusion criteria

1. Allergy or sensitivity to adhesive used for wearing the investigational device 2. Self-reported use of a pacemaker 3. Self-reported unstable diagnosed anxiety disorder 4. Self-reported sleep disorder requiring medical treatment 5. Self-reported skin conditions or sensitive skin around the area of application 6. Self-reported surgery in the past three months or individuals who have planned surgery during the course of the study 7. Alcohol intake average of ˃1 standard drink per day 8. Alcohol or drug abuse within the last 12 months that has required treatment 9. Current use of prescribed and/or over-the-counter (OTC) medications/supplements that may impact data recorded by the investigational device (see Section 7.3) 10. Participation in other clinical research studies 30 days prior to screening 11. Individuals who are unable to give informed consent 12. Any other condition or lifestyle factor, that may adversely affect the participant's ability to complete the study or its measures or pose significant risk to the participant

Design outcomes

Primary

MeasureTime frameDescription
The accuracy of the developed algorithm from the investigational device compared to daily self-report questionnaire via an app in characterizing Vasomotor symptoms.Day 0 to 14The accuracy of the developed algorithm from the investigational device compared to daily self-report questionnaire via an app in characterizing vasomotor symptoms. Questionnaire answers include not at all to extremely.
The accuracy of the developed algorithm from the investigational device compared to daily self-report questionnaire via an app in characterizing anxietyDay 0 to 14The accuracy of the developed algorithm from the investigational device compared to daily self-report questionnaire via an app in characterizing anxiety. Questionnaire answers include not at all to nearly everyday.
The accuracy of the developed algorithm from the investigational device compared to daily self-report questionnaire via an app in characterizing sleep qualityDay 0 to 14The accuracy of the developed algorithm from the investigational device compared to daily self-report questionnaire via an app in characterizing sleep quality. Questionnaire answers include terrible to very well.
The accuracy of the developed algorithm from the investigational device compared to daily self-report questionnaire via an app in characterizing perimenopausal symptoms considering confoundersDay 0 to 14The accuracy of the developed algorithm from the investigational device compared to daily self-report questionnaire via an app in characterizing perimenopausal symptoms considering confounders of warmer environmental conditions. Questionnaire answers include not at all to nearly all day.

Countries

Canada

Contacts

Primary ContactMarc Moulin, PhD
mmoulin@kgkscience.com+12267819094;ext=300

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026